Skip to main content

Table 2 HIV treatment data of adolescents aged 10–19 years old on ART and enrolled in the cross-sectional survey at Myittar Yeik Clinic, by sex, 2016

From: High levels of viral repression, malnutrition and second-line ART use in adolescents living with HIV: a mixed methods study from Myanmar

 TotalFemaleMaleP-value
# (%)# (%)# (%) 
Age (years) at ART start   0.513
<=592 (52)45 (47)47 (58) 
6–964 (36)38 (40)26 (32) 
10–1314 (7.9)9 (9.4)5 (6.2) 
14–197 (4.0)4 (4.2)3 (3.7) 
WHO status at cohort entry   0.007
141 (23)13 (14)28 (35) 
252 (29)32 (33)20 (25) 
372 (41)43 (45)29 (36) 
411 (6.2)8 (8.3)3 (3.7) 
Missing1 (0.6)0 (0.0)1 (1.2) 
CD4 count at cohort entry   0.625
< 20034 (19)22 (23)12 (15) 
200–35014 (7.9)6 (6.3)8 (9.9) 
351–50012 (6.8)7 (7.3)5 (6.2) 
> 50065 (37)33 (34)32 (40) 
Missing52 (29)28 (29)24 (30) 
Current ART regimen   0.090
First-line treatment139 (79)80 (83)59 (73) 
Second-line treatment38 (21)16 (17)22 (27) 
Mean time (years) on any ART regimen, SD6.6 (2.7)6.7 (2.7)6.5 (2.4)0.703
Mean time (years) on current ART regimen, SD2.1 (1.0)2.3 (1.0)1.9 (0.8)0.010
  1. Includes results up to 6 months after cohort entry